glycyrrhizic acid has been researched along with Diathesis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, X; Jiang, Y; Liu, C; Qu, F; Xi, H; Zhao, X; Zhao, Y | 1 |
| Cao, K; Chen, T; Fu, L; Sun, Q; Wang, J; Yang, H | 1 |
| Ito, M; Kobayashi, M; Pollard, RB; Suzuki, F; Utsunomiya, T | 1 |
1 review(s) available for glycyrrhizic acid and Diathesis
| Article | Year |
|---|---|
Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.
Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Antimalarials; Antiviral Agents; Basal Metabolism; Betacoronavirus; Cardiovascular Physiological Phenomena; Chloroquine; Congenital Abnormalities; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Susceptibility; Drug Combinations; Drug Delivery Systems; Female; Functional Residual Capacity; Glycyrrhizic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Interferon Type I; Lopinavir; Metformin; Nanoparticles; Oxygen Consumption; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Progesterone; Prognosis; Respiratory Physiological Phenomena; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Stillbirth; Ventilation-Perfusion Ratio | 2020 |
2 other study(ies) available for glycyrrhizic acid and Diathesis
| Article | Year |
|---|---|
The Anti-inflammatory Effects of HMGB1 Blockades in a Mouse Model of Cutaneous Vasculitis.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Cytokines; Disease Models, Animal; Disease Susceptibility; Gene Expression; Glycyrrhizic Acid; HMGB1 Protein; Immunohistochemistry; Mice; Vasculitis, Leukocytoclastic, Cutaneous | 2020 |
Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated type 2 T cell responses.
Topics: AIDS-Related Opportunistic Infections; Animals; Antibodies, Monoclonal; Antibody Formation; Antifungal Agents; Candida albicans; Candidiasis; CD4-Positive T-Lymphocytes; Disease Susceptibility; Glycyrrhizic Acid; Immunity, Innate; Interleukin-10; Interleukin-4; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Th2 Cells | 2000 |